New Risk • Jun 25
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹918.7m (US$9.73m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.1x net interest cover). Shares are highly illiquid. Earnings have declined by 26% per year over the past 5 years. Market cap is less than US$10m (₹918.7m market cap, or US$9.73m). Reported Earnings • May 26
Full year 2026 earnings released: EPS: ₹1.05 (vs ₹2.21 loss in FY 2025) Full year 2026 results: EPS: ₹1.05 (up from ₹2.21 loss in FY 2025). Revenue: ₹2.44b (up 27% from FY 2025). Net income: ₹13.3m (up ₹29.4m from FY 2025). Profit margin: 0.5% (up from net loss in FY 2025). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings. Ankündigung • May 19
Ambani Orgochem Limited to Report Second Half, 2026 Results on May 21, 2026 Ambani Orgochem Limited announced that they will report second half, 2026 results on May 21, 2026 New Risk • Nov 20
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹872.3m (US$9.83m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.7x net interest cover). Shares are highly illiquid. Earnings have declined by 25% per year over the past 5 years. Market cap is less than US$10m (₹872.3m market cap, or US$9.83m). Minor Risks Profit margins are more than 30% lower than last year (0.2% net profit margin). Shareholders have been diluted in the past year (19% increase in shares outstanding). Ankündigung • Nov 14
Ambani Orgochem Limited to Report First Half, 2026 Results on Nov 14, 2025 Ambani Orgochem Limited announced that they will report first half, 2026 results on Nov 14, 2025 Board Change • Sep 10
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Non-Executive Independent Director Prakash Mahanwar was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Ankündigung • Sep 04
Ambani Orgochem Limited, Annual General Meeting, Sep 27, 2025 Ambani Orgochem Limited, Annual General Meeting, Sep 27, 2025, at 12:00 Indian Standard Time. Board Change • Aug 18
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Non-Executive Independent Director Prakash Mahanwar was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. New Risk • Jul 07
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 19% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.2x net interest cover). Shares are highly illiquid. Earnings have declined by 14% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (19% increase in shares outstanding). Market cap is less than US$100m (₹991.8m market cap, or US$11.6m). Board Change • Jul 02
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Non-Executive Independent Director Prakash Mahanwar was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • May 15
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Non-Executive Independent Director Prakash Mahanwar was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Ankündigung • Feb 17
Ambani Orgochem Limited Resumes Commercial Productions of Manufacturing Plant Located At Dahej Industrial Area, Dist - Bharuch Ambani Orgochem Limited has resumed commercial productions of manufacturing plant located at D-3 167, 168 & D-3 169, Dahej Industrial Area, Dist Bharuch Gujarat 392 165 with effect from February 15, 2025. Valuation Update With 7 Day Price Move • Dec 13
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹136, the stock trades at a trailing P/E ratio of 76.3x. Average trailing P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 46% over the past three years. Valuation Update With 7 Day Price Move • Nov 08
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹105, the stock trades at a trailing P/E ratio of 22.2x. Average trailing P/E is 35x in the Chemicals industry in India. Total returns to shareholders of 4.5% over the past three years. New Risk • Nov 06
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.3x net interest cover). High level of non-cash earnings (33% accrual ratio). Market cap is less than US$10m (₹609.8m market cap, or US$7.24m). Minor Risk Share price has been volatile over the past 3 months (7.8% average weekly change). Valuation Update With 7 Day Price Move • Oct 14
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹92.65, the stock trades at a trailing P/E ratio of 19.6x. Average trailing P/E is 35x in the Chemicals industry in India. Total loss to shareholders of 13% over the past three years. Ankündigung • Sep 16
Ambani Orgochem Limited, Annual General Meeting, Sep 30, 2024 Ambani Orgochem Limited, Annual General Meeting, Sep 30, 2024, at 16:00 Indian Standard Time. Board Change • Jul 25
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Non-Executive Independent Director Prakash Mahanwar was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Ankündigung • Jul 23
Ambani Organics Limited Announces Resignation of Dilipkumar Vikamchand Mehta as Non-Executive Director Ambani Organics Limited announced resignation of Dilipkumar Vikamchand Mehta as Non-Executive Director, effective July 23, 2024. New Risk • May 28
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.8x net interest cover). Shares are highly illiquid. Earnings have declined by 4.4% per year over the past 5 years. High level of non-cash earnings (22% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Profit margins are more than 30% lower than last year (0.4% net profit margin). Market cap is less than US$100m (₹844.3m market cap, or US$10.2m). Ankündigung • Feb 22
Ambani Organics Limited Announces Directorate Appointments Directors of Ambani Organics Limited at its meeting held on Tuesday, February 20, 2024 has approved the following. Mr. Bhavin Jitendra Patel, Date of Birth 14 March 1996. Age is 27 years. Mr. Bhavin Jitendra Patel is appointed as the Additional Director (Non-Executive Director) of the Company with effect from February 20, 2024 liable to retire by rotation. Mr. Bhavin Jitendra Patel has Experience of four years with Ambani Organic Limited. He has qualification of B.E. Petrochemical Engineering. Currently, he is designated as Genearal Manager at Dahej Plant of Ambani Organic Limited. Mr. Neerajkumar Amarjeet Pandey, Date of Birth 02 January 1972 Age 52 years, Mr. Neerajkumar Amarjeet Pandey is appointed as the Additional Director (Non- Executive Director) of the Company with effect from February 20, 2024 liable to retire by rotation. Mr. Neerajkumar Amarjeet Pandey has over Three Decades of experience out of which 22 years with Ambani Organic Limited. He has qualification of BSc (Chemical). Currently, he is designted as Genearal Manager at Tarapur Plant of Ambani Organic Limited. New Risk • Nov 18
New major risk - Revenue and earnings growth Earnings have declined by 4.4% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.7x net interest cover). Earnings have declined by 4.4% per year over the past 5 years. High level of non-cash earnings (22% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Profit margins are more than 30% lower than last year (0.4% net profit margin). Market cap is less than US$100m (₹890.9m market cap, or US$10.7m). Valuation Update With 7 Day Price Move • Sep 28
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₹119, the stock trades at a trailing P/E ratio of 59.2x. Average trailing P/E is 27x in the Chemicals industry in India. Total returns to shareholders of 181% over the past three years. New Risk • Sep 16
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.0% Last year net profit margin: 1.6% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.2x net interest cover). High level of non-cash earnings (27% accrual ratio). Minor Risks Profit margins are more than 30% lower than last year (1.0% net profit margin). Market cap is less than US$100m (₹932.7m market cap, or US$11.2m). Ankündigung • Sep 09
Ambani Organics Limited, Annual General Meeting, Sep 29, 2023 Ambani Organics Limited, Annual General Meeting, Sep 29, 2023, at 17:00 Indian Standard Time. Agenda: To receive, consider and adopt the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2023, together with the Reports of the Board of Directors and the Auditors thereon; to consider and appoint a Director in place of Mr. Sharad P Kothari , who retires by rotation at this Annual General Meeting and being eligible has offered himself for re- appointment; to consider and ratify the remuneration payable to the Cost Auditor appointed by the Board of Directors of the Company for the financial year 2022-2023. Valuation Update With 7 Day Price Move • Aug 24
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₹141, the stock trades at a trailing P/E ratio of 45.9x. Average trailing P/E is 26x in the Chemicals industry in India. Total returns to shareholders of 147% over the past three years. New Risk • Jul 01
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹816.6m (US$9.95m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.4x net interest cover). Share price has been highly volatile over the past 3 months (9.9% average weekly change). High level of non-cash earnings (27% accrual ratio). Market cap is less than US$10m (₹816.6m market cap, or US$9.95m). Minor Risk Shareholders have been diluted in the past year (27% increase in shares outstanding). Valuation Update With 7 Day Price Move • Jun 06
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹149, the stock trades at a trailing P/E ratio of 48.6x. Average trailing P/E is 21x in the Chemicals industry in India. Reported Earnings • Jun 01
Full year 2023 earnings released: EPS: ₹1.07 (vs ₹3.06 in FY 2022) Full year 2023 results: EPS: ₹1.07. Revenue: ₹1.33b (up 6.5% from FY 2022). Net income: ₹19.8m (up 15% from FY 2022). Profit margin: 1.5% (up from 1.4% in FY 2022). The increase in margin was driven by higher revenue. Valuation Update With 7 Day Price Move • Apr 25
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹103, the stock trades at a trailing P/E ratio of 36x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 93% over the past three years. Board Change • Apr 10
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Mar 02
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Feb 07
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Nov 23
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Oct 22
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Ankündigung • Sep 05
Ambani Organics Limited, Annual General Meeting, Sep 26, 2022 Ambani Organics Limited, Annual General Meeting, Sep 26, 2022, at 15:00 Indian Standard Time. Agenda: To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2022, together with the Reports of the Board of Directors and the Auditors thereon; to receive, consider and adopt the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2022, together with the Report of the Auditors thereon; to appoint a Director in place of Mr. Dilipkumar Vikramchand, who retires by rotation at this Annual General Meeting and being eligible has offered himself for re-appointment; and to re-appoint M/s. Shambhu Gupta & Co, Chartered Accountants as the statutory auditors of the company and to fix their remuneration. Board Change • Aug 17
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Jun 17
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • May 11
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Mar 22
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Mar 07
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Board Change • Feb 15
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Non-Executive Non-Independent Director Dilipkumar Mehta was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Sep 16
Investor sentiment improved over the past week After last week's 16% share price gain to ₹68.60, the stock trades at a trailing P/E ratio of 20.5x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 3.8% over the past three years. Reported Earnings • Jun 30
Full year 2021 earnings released: EPS ₹3.35 (vs ₹2.72 in FY 2020) The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2021 results: Revenue: ₹873.6m (up 19% from FY 2020). Net income: ₹17.0m (up 23% from FY 2020). Profit margin: 1.9% (in line with FY 2020). Valuation Update With 7 Day Price Move • Jun 18
Investor sentiment deteriorated over the past week After last week's 18% share price decline to ₹72.85, the stock trades at a trailing P/E ratio of 32.3x. Average trailing P/E is 22x in the Chemicals industry in India. Valuation Update With 7 Day Price Move • May 29
Investor sentiment deteriorated over the past week After last week's 23% share price decline to ₹80.95, the stock trades at a trailing P/E ratio of 35.9x. Average trailing P/E is 20x in the Chemicals industry in India. Valuation Update With 7 Day Price Move • May 06
Investor sentiment improved over the past week After last week's 20% share price gain to ₹60.00, the stock trades at a trailing P/E ratio of 26.6x. Average trailing P/E is 19x in the Chemicals industry in India. Ankündigung • Jul 17
Ambani Organics Limited to Report Fiscal Year 2020 Results on Jul 17, 2020 Ambani Organics Limited announced that they will report fiscal year 2020 results on Jul 17, 2020 
